Elanco Animal Health Incorporated

12.77-0.1000-0.78%Vol 4.76M1Y Perf 2.39%
Dec 7th, 2023 16:00 DELAYED
BID12.10 ASK13.18
Open13.06 Previous Close12.87
Pre-Market- After-Market-
 - -%  - -
Target Price
17.25 
Analyst Rating
Hold 2.56
Potential %
35.08 
Finscreener Ranking
★★★     48.29
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★+     49.31
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     39.32
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
71.81 
Earnings Rating
Neutral
Market Cap6.29B 
Earnings Date
7th Nov 2023
Alpha-0.02 Standard Deviation0.12
Beta1.14 

Today's Price Range

12.6113.12

52W Range

7.8814.69

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
2.98%
1 Month
17.70%
3 Months
10.18%
6 Months
36.58%
1 Year
2.39%
3 Years
-57.13%
5 Years
-61.96%
10 Years
-

TickerPriceChg.Chg.%
ELAN12.77-0.1000-0.78
AAPL194.271.95001.01
GOOG138.457.02005.34
MSFT370.952.15000.58
XOM98.42-0.6900-0.70
WFC45.400.90002.02
JNJ155.40-1.2200-0.78
FB196.640.99000.51
GE119.48-0.3300-0.28
JPM156.790.48000.31
Financial StrengthValueIndustryS&P 500US Markets
0.90
2.00
0.45
0.87
0.50
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
56.50
2.70
17.90
-6.60
-0.67
RevenueValueIndustryS&P 500US Markets
3.43B
7.23
15.21
10.33
Earnings HistoryEstimateReportedSurprise %
Q03 20230.120.1850.00
Q02 20230.050.18260.00
Q01 20230.290.4555.17
Q04 20220.130.1946.15
Q03 20220.160.2025.00
Q02 20220.260.3638.46
Q01 20220.350.362.86
Q04 20210.170.2123.53
Earnings Per EndEstimateRevision %Trend
12/2023 QR0.1110.00Positive
12/2023 FY0.928.24Positive
3/2024 QR0.313.33Positive
12/2024 FY0.89-3.26Negative
Next Report Date-
Estimated EPS Next Report0.12
Estimates Count7
EPS Growth Next 5 Years %1.80
Volume Overview
Volume4.76M
Shares Outstanding492.80K
Shares Float490.63M
Trades Count34.17K
Dollar Volume60.88M
Avg. Volume5.37M
Avg. Weekly Volume5.74M
Avg. Monthly Volume5.18M
Avg. Quarterly Volume5.19M

Elanco Animal Health Incorporated (NYSE: ELAN) stock closed at 12.77 per share at the end of the most recent trading day (a -0.78% change compared to the prior day closing price) with a volume of 4.76M shares and market capitalization of 6.29B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 6080 people. Elanco Animal Health Incorporated CEO is Jeffrey N. Simmons.

The one-year performance of Elanco Animal Health Incorporated stock is 2.39%, while year-to-date (YTD) performance is 4.5%. ELAN stock has a five-year performance of -61.96%. Its 52-week range is between 7.88 and 14.69, which gives ELAN stock a 52-week price range ratio of 71.81%

Elanco Animal Health Incorporated currently has a PE ratio of -52.90, a price-to-book (PB) ratio of 0.89, a price-to-sale (PS) ratio of 1.76, a price to cashflow ratio of 9.40, a PEG ratio of -29.39, a ROA of -0.83%, a ROC of 0.15% and a ROE of -1.81%. The company’s profit margin is -0.67%, its EBITDA margin is 17.90%, and its revenue ttm is $3.43 Billion , which makes it $7.23 revenue per share.

Of the last four earnings reports from Elanco Animal Health Incorporated, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.12 for the next earnings report. Elanco Animal Health Incorporated’s next earnings report date is -.

The consensus rating of Wall Street analysts for Elanco Animal Health Incorporated is Hold (2.56), with a target price of $17.25, which is +35.08% compared to the current price. The earnings rating for Elanco Animal Health Incorporated stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Elanco Animal Health Incorporated has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Elanco Animal Health Incorporated has a Buy technical analysis rating based on Technical Indicators (ADX : 12.75, ATR14 : 0.44, CCI20 : 124.60, Chaikin Money Flow : 0.16, MACD : 0.68, Money Flow Index : 75.13, ROC : 7.49, RSI : 71.00, STOCH (14,3) : 73.41, STOCH RSI : 0.77, UO : 58.71, Williams %R : -26.59), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Elanco Animal Health Incorporated in the last 12-months were: Simmons Jeffrey (Buy at a value of $144 000)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (33.33 %)
3 (33.33 %)
3 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
5 (55.56 %)
5 (55.56 %)
5 (55.56 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (11.11 %)
1 (11.11 %)
1 (11.11 %)
Summary RatingModerate Buy
2.56
Moderate Buy
2.56
Moderate Buy
2.56

Elanco Animal Health Incorporated

Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Latin America, and the Asia Pacific with the highest revenue from the North America segment. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

CEO: Jeffrey N. Simmons

Telephone: +1 877 352-6261

Address: 2500 Innovation Way, Greenfield 46140, IN, US

Number of employees: 6 080

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

58%42%

Bearish Bullish

57%43%

 

TipRanks News for ELAN

Tue, 08 Aug 2023 07:16 GMT Elanco Animal Health (ELAN) Receives a New Rating from Barclays

- TipRanks. All rights reserved.

News

Stocktwits